Related Articles
Difference in expression of two neurokinin‑1 receptors in adenoma and carcinoma from patients that underwent radical surgery for colorectal carcinoma
Aprepitant inhibits the progression of esophageal squamous cancer by blocking the truncated neurokinin‑1 receptor
Targeting the neurokinin-1 receptor inhibits growth of human colon cancer cells
Neurokinin-2 receptor polymorphism predicts lymph node metastasis in colorectal cancer patients
Antitumor activity of neurokinin-1 receptor antagonists in MG-63 human osteosarcoma xenografts